gsId | name | species | plateform | superseries | approved | Actions |
---|
GS-DT-58 | Jourdan, B to Plasma cells | GS-ORG-1 | GS-PL-1 | | 1 | |
GS-DT-53 | Clozel, DLBCL cell lines | GS-ORG-1 | GS-PL-23 | | 1 | |
GS-DT-43 | Human B cells to plasma cells (in-vitro) | GS-ORG-1 | GS-PL-1 | | 1 | |
GS-DT-52 | Mulligan, bortezomib monotherapy in myeloma | GS-ORG-1 | GS-PL-22 | | 1 | |
GS-DT-51 | Herold, chronic lymphocytic leukemia, HGU133AB | GS-ORG-1 | GS-PL-22 | GS-SS8 | 1 | |
GS-DT-50 | Herold, chronic lymphocytic leukemia, HGU133P | GS-ORG-1 | GS-PL-1 | GS-SS8 | 1 | |
GS-DT-49 | Staudt, Follicular lymphoma with or not t(14;18) | GS-ORG-1 | GS-PL-22 | | 1 | |
GS-DT-47 | Kirschner-Schwabe, Acute lymphoblastic leukemia | GS-ORG-1 | GS-PL-2 | | 1 | |
GS-DT-22 | Denkert, Ovarian cancer | GS-ORG-1 | GS-PL-2 | | 1 | |
GS-DT-21 | Bonome, Ovarian cancer | GS-ORG-1 | GS-PL-2 | | 1 | |
GS-DT-14 | Arkansas, Myeloma (Molecular groups, 1q21-Amp) | GS-ORG-1 | GS-PL-1 | | 1 | |
GS-DT-20 | Lenz, diffuse large B cell lymphoma | GS-ORG-1 | GS-PL-1 | | 1 | |